- Home
Presenter Disclosures
Disclosures are for anything of value received from a commercial interest* or financial relationship** which relates directly or indirectly to the subject of a presentation. All conference presenters are required to declare any financial or industry disclosures during the submission process. Having an interest in or an affiliation with a corporate organization may or may not prevent a speaker from making a presentation. ILCA must be made aware of the relationship in advance.
Circumstances create a conflict of interest when a speaker has an opportunity to affect presentation content about products or services of a commercial interest with which the speaker has a financial relationship.
ILCA will not approve education that is not International Code of Marketing of Breast-milk Substitutes compliant. We require our speakers to state their compliance with the International Code. Should any speaker be found in violation of the International Code, ILCA reserves the right to cancel the presentation and the speaker’s involvement with conference activities and nullify prior agreements.
All speakers must state their disclosures verbally and include them in writing on the disclosure slide at the beginning of their presentation.
When potential conflicts of interest are disclosed that cannot be easily resolved, ILCA’s Compliance Team or the International Code Committee will review the situation and make the final decision on whether the presentation will be included in the program.
*A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.**A relevant financial relationship is a financial relationship in any amount occurring within the past 12 months that creates a conflict of interest.
Presenters with No Disclosures
The following presenters have indicated they have no significant financial interest or other relations with the manufacturer(s) of any product(s) or provider(s) of any services they intend to discuss relating to the subject matter of their presentations.
Ayah Al Far Siti Mariam Ali Jackeline Ashiyama Ivy Bagley Holly Beck Marie-Caroline Bergouignan Deborah Bucsh Suzanne Campbell Nina Chad Ayisha Chandni Jayne Charlamb Crystal Cooper Joan Dodgson 静 袁 Adrienne Fuson Linda Goldman |
Taghreed Hawsawi Shela Hirani Hamizah Ismail Nurjasmine Aida Jamani Wafa Khasawneh Robin LaGrandeur Sonia Lai Annabelle Mackenzie Sally Mahmoud Carrie Miller Davia Moss Samira Moughrabi Mariana Oliveira Rebecca Powell Janet Regts |
Aubrey Richardson Shyamala Sathiaseelan Sonia Semenic Kathy Shats Kendra Shelby Natalie Shenker Linda Smith Samah Soliman Syed Abdul Khaliq Syed Abd Hamid Hairin Anisa Tajuddin Angela Tatum Malloy Cecilia Tomori Maryelena Vargas Elaine Webber Nadine Wodwaski |
Presenters with Commercial Disclosures
The following presenters have indicated the following financial interest or other relationship with a manufacturer and/or provider:
Cathy Carothers has received CHAMPS grants to assist with IPE promotion Kristina Chamberlain is employed by the University of California San Diego Extension program mentioned in the presentation Saray Hill receives and employee salary from IBLCE Nekisha Killings is the creator/owner of the The Melanated Mammary Atlas®, a professional resource that will be a source of images in the presentation Sara Lake receives and employee salary from IBLCE Janice Tedder is the president and CEO of HUG Your Baby Kristin Tully would like to disclose as the inventor of a patented medical device (postnatal unit bassinet) in addition to being the founder and Chief Scientist at Couplet Care, LLC from which a salary is not received but equity in the company is held |
Presenters with FDA Clearance Disclosures
The following presenters have indicated the use of pharmaceuticals and/or medical devices:
Siti Mariam Ali - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. Ivy M. Bagley - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. Jayne R. Charlamb - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation. Taghreed Hawsawi - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. Davia Moss - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation. Kendra L. Shelby - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. Hairin Anisa Tajuddin - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. |
Conference Disclaimer
Statements of fact or opinion expressed by presenters are solely the responsibility of those presenters. ILCA does not assume responsibility for the accuracy of the material and such material does not represent the official policy, opinion, recommendation, or endorsement of ILCA. The appearance and content of advertisements contained in the final program or registration inserts do not constitute a guarantee or an endorsement of the quality or value of the advertised products or services or of the claims made for them by their advertisers.